| Year |
Citation |
Score |
| 2017 |
Wobst HJ, Denk F, Oliver PL, Livieratos A, Taylor TN, Knudsen MH, Bengoa-Vergniory N, Bannerman D, Wade-Martins R. Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Scientific Reports. 7: 43198. PMID 28233851 DOI: 10.1038/Srep43198 |
0.326 |
|
| 2015 |
Alter SP, Stout KA, Lohr KM, Taylor TN, Shepherd KR, Wang M, Guillot TS, Miller GW. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology. PMID 26428905 DOI: 10.1016/J.Expneurol.2015.09.016 |
0.592 |
|
| 2014 |
Taylor TN, Potgieter D, Anwar S, Senior SL, Janezic S, Threlfell S, Ryan B, Parkkinen L, Deltheil T, Cioroch M, Livieratos A, Oliver PL, Jennings KA, Davies KE, Ansorge O, et al. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease. 62: 193-207. PMID 24121116 DOI: 10.1016/J.Nbd.2013.10.005 |
0.567 |
|
| 2014 |
Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 76: 97-105. PMID 24025942 DOI: 10.1016/J.Neuropharm.2013.08.033 |
0.78 |
|
| 2013 |
Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, Parkkinen L, Senior SL, Anwar S, Ryan B, Deltheil T, Kosillo P, Cioroch M, Wagner K, Ansorge O, et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proceedings of the National Academy of Sciences of the United States of America. 110: E4016-25. PMID 24082145 DOI: 10.1073/Pnas.1309143110 |
0.608 |
|
| 2013 |
Alter SP, Taylor TN, Sullivan P, Goldstein DS, Miller GW. Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 125. DOI: 10.1016/B978-0-12-800044-1.00108-2 |
0.776 |
|
| 2011 |
Taylor TN, Caudle WM, Miller GW. VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease. Parkinson's Disease. 2011: 124165. PMID 21403896 DOI: 10.4061/2011/124165 |
0.811 |
|
| 2010 |
Taylor TN, Greene JG, Miller GW. Behavioral phenotyping of mouse models of Parkinson's disease. Behavioural Brain Research. 211: 1-10. PMID 20211655 DOI: 10.1016/J.Bbr.2010.03.004 |
0.59 |
|
| 2009 |
Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8103-13. PMID 19553450 DOI: 10.1523/Jneurosci.1495-09.2009 |
0.757 |
|
| 2008 |
Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides. 42: 423-34. PMID 18533255 DOI: 10.1016/J.Npep.2008.04.003 |
0.79 |
|
| 2007 |
Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8138-48. PMID 17652604 DOI: 10.1523/Jneurosci.0319-07.2007 |
0.757 |
|
| Show low-probability matches. |